Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: Combined cDNA suppression subtractive hybridization and microarray study

Cancer

Volumn 104, Issue 11, 2005, Pages 2409-2416

  Feng, Hui Chen ^a   Tsao, Sai Wah ^a   Ngan, Hextan Y S ^a   Xue, Wei Cheng ^a   Chiu, Pui Man ^a   Cheung, Annie N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

cDNA microarray; FTL; Gestational trophoblastic neoplasia; IGFBP1; Suppression subtractive hybridization

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; FERRITIN; FERRITIN LIGHT POLYPEPTIDE; POLYPEPTIDE; SOMATOMEDIN BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL INVASION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DNA LIBRARY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; METASTASIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLACENTA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TISSUE SPECIFICITY; TROPHOBLASTIC TUMOR;

ADOLESCENT; ADULT; DNA, COMPLEMENTARY; FEMALE; FERRITINS; HUMANS; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; TROPHOBLASTIC NEOPLASMS; UTERINE NEOPLASMS;

EID: 28044446312     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21483     Document Type: Article

References (43)

1. Cheung AN. Pathology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003;17:849-868.
2. Shih IM, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesion. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. (5th ed). New York: Springer, 2002:1193-1250.
3. Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In: Fox H, Wells M, editors. Haines & Taylor obstetrical and gynaecological pathology. (5th ed). Edinburgh: Churchill Livingstone, 2003:1359-1430.
4. Wong LC, Ngan HY, Cheng DK, Ng TY. Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol. 2000;183:1579-1582.
5. Ng TY, Wong LC. Diagnosis and management of gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynaecol. 2003;17:893-903.
6. Soper JT, Mutch DG, Schink JC. Diagnosis and treatment of gestational trophoblastic disease: ACOG practice bulletin no. 53. Gynecol Oncol. 2004;93:575-585.
7. Wong SY, Ngan HY, Chan CC, Cheung AN. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Mod Pathol. 1999;12:1025-1033.
8. Chiu PM, Ngan YS, Khoo US, Cheung AN. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology. 2001;38:243-249.
9. Cheung AN, Zhang DK, Liu Y, Ngan HY, Shen DH, Tsao SW. Telomerase activity in gestational trophoblastic disease. J Clin Pathol. 1999;52:588-592.
10. Fong PY, Xue WC, Ngan HY, et al. Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome. Cancer. 2005;103:268-276.
11. Feng HC, Tsao SW, Ngan HY, et al. Differential gene expression identified in complete hydatidiform mole by combining suppression subtractive hybridization and cDNA microarray. Placenta. 2005; JulI 16:[Epub ahead of print].
12. Diatchenko L, Lau YF, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996;93:6025-6030.
13. Kwok Fung LA, Liu Y, Wang X, et al. Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization. Biochim Biophys Acta. 2001;1520:131-140.
14. Lai CY, Chan KY, Khoo US, et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol. 2004;17:40-48.
15. Cheung AN, Khoo US, Lai CY, et al. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer. 2004;100:1411-1417.
16. Kwok Fung Lo A, Liu Y, Wang X, et al. Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization. Biochim Biophys Acta. 2001;1520:131-140.
17. Feng HC, Choy MY, Deng W, et al. Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1). J Soc Gynecol Investig. 2005;12:e21-32.
18. Patel P, Boyd CA, Johnston DG, Williamson C. Analysis of GAPDH as a standard for gene expression quantification in human placenta. Placenta. 2002;23:697-698.
19. Feng H, Cheung AN, Xue WC, et al. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma. Gynecol Oncol. 2004;94:375-382.
20. Bo M, Boime I. Identification of the transcriptionally active genes of the chorionic gonadotropin beta gene cluster in vivo. J Biol Chem. 1992;267:3179-3184.
21. Xu RH, Chen X, Li DS, et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol. 2002;20:1261-1264.
22. GeneAmp 5700 user's manual. Absolute and relative quantitation. Foster City, CA: PE Applied Biosystems, 1998.
23. Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res. 1995;217:419-427.
24. Hamilton GS, Lysiak JJ, Han VK, Lala PK. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res. 1998;244:147-156.
25. Gleeson LM, Chakraborty C, McKinnon T, Lala PK. Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway. J Clin Endocrinol Metab. 2001;86:2484-2493.
26. McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab. 2001;86:3665-3674.
27. Irwin JC, Giudice LC. Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast alpha5beta1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. Growth Horm IGF Res. 1998;8:21-31.
28. Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe pre-eclampsia. Am J Obstet Gynecol. 1997;176:751-757.
29. Fisher RA, Hodges MD. Genomic imprinting in gestational trophoblastic disease-a review. Placenta. 2003;24(Suppl A):S111-S118.
30. Netzel-Arnett S, Mitola DJ, Yamada SS, et al. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity. J Biol Chem. 2002;277:45154-45161.
31. Johnson GA, Burghardt RC, Spencer TE, Newton GR, Ott TL, Bazer FW. Ovine osteopontin: II. Osteopontin and alpha(v)-beta(3) integrin expression in the uterus and conceptus during the periimplantation period. Biol Reprod. 1999;61:892-899.
32. Batorfi J, Fulop V, Kim JH, et al. Osteopontin is downregulated in hydatidiform mole. Gynecol Oncol. 2003;89:134-139.
33. Xue WC, Chan KY, Feng HC, et al. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn. 2004;6:326-334.
34. Drysdale JW. Microheterogeneity in ferritin molecules. Biochim Biophys Acta. 1970;207:256-258.
35. Fang R, Aust AE. Induction of ferritin synthesis in human lung epithelial cells treated with crocidolite asbestos. Arch Biochem Biophys. 1997;340:369-375.
36. Maymon R, Weinraub Z, Bukovsky I, Moroz C. Placental isoferritin levels during first trimester of normal and complete molar gestations. Placenta. 1995;16:455-460.
37. Algarra I, Cabrera T, Garrido F. The HLA crossroad in tumor immunology. Hum Immunol. 2000;61:65-73.
38. Ngan HY. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2004;14:202-205.
39. Liu VW, Shi HH, Cheung AN, et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. 2001;61:5998-6001.
40. Liu VW, Yang HJ, Wang Y, et al. High frequency of mitochondrial genome instability in human endometrial carcinomas. Br J Cancer. 2003;89:697-701.
41. Chiu PM, Liu VW, Ngan HY, Khoo US, Cheung AN. Detection of mitochondrial DNA mutations in gestational trophoblastic disease. Hum Mutat. 2003;22:177-185.
42. Wulbrand U, Remmert G, Zofel P, Wied M, Arnold R, Fehmann HC. mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours. Eur J Clin Invest. 2000;30:729-739.
43. Pattyn F, Speleman F, De Paepe A, Vandesompele J. RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res. 2003;31:122-123.